HRP20080542T3 - Acetamidni derivati epipodofilotoksina, postupak njihove priprave i njihova terapijska primjena kaoantikancerogena sredstva - Google Patents

Acetamidni derivati epipodofilotoksina, postupak njihove priprave i njihova terapijska primjena kaoantikancerogena sredstva

Info

Publication number
HRP20080542T3
HRP20080542T3 HR20080542T HRP20080542T HRP20080542T3 HR P20080542 T3 HRP20080542 T3 HR P20080542T3 HR 20080542 T HR20080542 T HR 20080542T HR P20080542 T HRP20080542 T HR P20080542T HR P20080542 T3 HRP20080542 T3 HR P20080542T3
Authority
HR
Croatia
Prior art keywords
radical
hydrogen atom
group
alkyl radical
independently
Prior art date
Application number
HR20080542T
Other languages
English (en)
Inventor
Imbert Thierry
Guminski Yves
Barret Jean-Marc
Kruczinski Anna
Original Assignee
Pierre Fabre Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament filed Critical Pierre Fabre Medicament
Publication of HRP20080542T3 publication Critical patent/HRP20080542T3/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Spojevi opće formule (I) (I) naznačeni time daR1i R2 neovisno jedan od drugog predstavljaju atom vodika ili metilni radikal, R3 i A zajedno tvore C3-C8 prsten, iliR3 predstavlja radikal odabran iz sljedeće skupine: atom vodika C1-C4 alkilni radikal i benzilni radikal te A predstavlja radikal odabran iz sljedeće skupine: atom vodika C1-C4 alkilniradikal i benzilni radikal te skupina formule (II) (II) u kojoja varira od 2 do 5, R4 i B zajedno tvore C3-C8 prsteniliR4 predstavlja radikal odabran iz sljedeće skupine: atom vodika C1-C4 alkilni radikal i benzilni radikal, moguće je da su R3 i R4spojeni alkilenskim lancem koji sadrži 2 ili 3 atoma ugljika, a B predstavlja radikal odabran iz sljedeće skupine: - atom vodika, - C1-C4 alkilni radikal, - benzilni radikal, - skupina formule (III)(III) u kojoj b i c variraju neovisno jedan od drugog od 2 do 5, a R5 do R7 neovisno jedan od drugog predstavljaju radikal odabran od sljedećih: atomvodika C1-C4 alkilni radikal i benzilni radikal, a moguće je da R4 i R5 i/ili R5 i R6 i/ili R6 i R7budu spojeni alkilenskim lancem koji sadrži 2 do 3 atom ugljika, - te skupina formule (IV) (IV) u kojoj c varira od 2 do 5, a R8 do R9 neovisno jedan od drugog predstavljaju atom vodika ili C1-C5 alkilni radikal, a moguće je da R4 i R8 budu spojenialkilenskim lancem koji sadrži 2 do 3 atom ugljika, ili R8 i R9 zajedno tvore C3-C8 prsten, ili njihove farmaceutski prihvatljive soli, posebno soli nastale adicijom anorganskih ili organskih kiselina. Patent sadrži još 13 patentnih zahtjeva.
HR20080542T 2004-04-16 2008-10-24 Acetamidni derivati epipodofilotoksina, postupak njihove priprave i njihova terapijska primjena kaoantikancerogena sredstva HRP20080542T3 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0404053A FR2869035B1 (fr) 2004-04-16 2004-04-16 Derives (poly)aminoalkylaminoacetamide d'epipodophyllotoxine leur procede de preparation et leurs applications en therapeutique comme agent anticancereux
PCT/IB2005/001268 WO2005100363A1 (en) 2004-04-16 2005-04-14 (poly) aminoacetamide derivatives of epipodophyllotoxin their process of preparation and their applications in therapeutics as anticancer agents

Publications (1)

Publication Number Publication Date
HRP20080542T3 true HRP20080542T3 (hr) 2008-12-31

Family

ID=34944659

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20080542T HRP20080542T3 (hr) 2004-04-16 2008-10-24 Acetamidni derivati epipodofilotoksina, postupak njihove priprave i njihova terapijska primjena kaoantikancerogena sredstva

Country Status (25)

Country Link
US (3) US7846926B2 (hr)
EP (1) EP1742952B1 (hr)
JP (1) JP4876070B2 (hr)
CN (1) CN1946727B (hr)
AR (1) AR048607A1 (hr)
AT (1) ATE402938T1 (hr)
AU (1) AU2005233382C1 (hr)
BR (1) BRPI0509912B8 (hr)
CA (1) CA2562617C (hr)
CY (1) CY1108444T1 (hr)
DE (1) DE602005008578D1 (hr)
DK (1) DK1742952T3 (hr)
ES (1) ES2311985T3 (hr)
FR (1) FR2869035B1 (hr)
HK (1) HK1095812A1 (hr)
HR (1) HRP20080542T3 (hr)
MX (1) MXPA06011886A (hr)
MY (1) MY137712A (hr)
PL (1) PL1742952T3 (hr)
PT (1) PT1742952E (hr)
RS (1) RS50628B (hr)
SI (1) SI1742952T1 (hr)
TW (1) TWI350288B (hr)
WO (1) WO2005100363A1 (hr)
ZA (1) ZA200609055B (hr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2888849B1 (fr) 2005-07-19 2007-10-05 Pierre Fabre Medicament Sa Procede de preparation de la 4b-amino-4'-demethyl-4-desoxypodophyllotoxine
FR2919287B1 (fr) * 2007-07-26 2012-10-12 Pf Medicament Nouveaux derives fluorescents de polyamines, leur procede de preparation et leurs applications en tant qu'outils de diagnostic dans le traitement des tumeurs cancereuses.
FR2921369B1 (fr) * 2007-09-25 2014-07-11 Pf Medicament Nouveau procede de preparation de derives (poly) aminoalkylaminoacetamide d'epipodophyllotoxine,utiles pour leurs applications en therapeutique comme agent anticancereux.
FR2921368B1 (fr) * 2007-09-25 2012-10-12 Pf Medicament Nouveau procede de synthese de derives anticancereux de (poly) aminoalkylaminoacetamide d'epipodophyllotoxine.
FR2935143B1 (fr) * 2008-08-19 2010-12-03 Pf Medicament Nouveaus derives (poly)aminoalkylaminoalkylamides, alkyl-urees, ou alkyl-sulfonamides d'epipodophyllotoxine, leur procede de preparation et leur application en therapeuthique comme agent cancereux
US8507717B2 (en) 2008-12-31 2013-08-13 Dow Global Technologies Llc Production of substituted phenylene aromatic diesters
BRPI0918698A8 (pt) 2008-12-31 2017-09-19 Grace W R & Co Composição de procatalisador e processo para produzir um polímero baseado em olefina
MX2012006370A (es) * 2009-12-02 2012-09-07 Dow Global Technologies Llc Compuestos de dicarbonato puenteados por dos atomos como donadores internos en catalizadores para la fabricacion de polipropileno.
WO2011068775A1 (en) 2009-12-02 2011-06-09 Dow Global Technologies Inc. Three and four atom bridged dicarbonate compounds as internal donors in catalysts for polypropylene manufacture
CN102234283B (zh) 2010-04-23 2013-06-12 湖北工业大学 4′-去甲基表鬼臼毒素衍生物及其合成方法和应用
WO2012063250A1 (en) * 2010-11-11 2012-05-18 Council Of Scientific And Industrial Research Substituted 4-beta-acrylamidopodophyllotoxin congeners as antitumour antibiotics and the process for preparation thereof
FR2967675B1 (fr) 2010-11-24 2015-02-27 Pf Medicament Derives fluorescents de cyanines polyamines en tant que sonde de diagnostic
CN105037379B (zh) * 2014-04-25 2017-12-19 上海医药工业研究院 鬼臼毒素衍生物、其制备方法、药物组合物及应用
CN104926841A (zh) * 2015-06-30 2015-09-23 遵义医学院 青蒿琥酯与鬼臼毒素偶联物在抗白血病药物中的应用及制备方法
WO2018234574A1 (en) 2017-06-22 2018-12-27 Ygm Consult Sas COMBINATORY THERAPY FOR THE TREATMENT OF CANCER
CN113801129A (zh) * 2021-09-30 2021-12-17 大连民族大学 一种鬼臼毒素脂质衍生物、纳米载体及其制备方法和在肿瘤治疗中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6323884A (ja) * 1986-07-17 1988-02-01 Nippon Kayaku Co Ltd 新規ポドフイロトキシン誘導体
US5300500A (en) * 1989-02-23 1994-04-05 The University Of North Carolina At Chapel Hill 4 beta-amino podophyllotoxin analog compounds and methods
US5332811A (en) * 1989-09-12 1994-07-26 The University Of North Carolina At Chapel Hill Etopside analogs
CN1068330A (zh) * 1991-07-03 1993-01-27 国家医药管理局上海医药工业研究院 4-氮取代-4-脱氧-4′-去甲表鬼臼毒素衍生物及其合成方法
FR2725990B1 (fr) * 1994-10-21 1997-01-10 Pf Medicament Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux
FR2742439B1 (fr) * 1995-12-14 1998-03-06 Pf Medicament Procede de preparation de la 4'-demethylepipodophyllotoxine a partir de la podophyllotoxine
FR2810321B1 (fr) * 2000-06-20 2002-07-26 Adir Nouveaux derives de podophyllotoxine carbamate et thiocarbamate, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE60205470T2 (de) 2002-03-28 2006-05-24 Council Of Scientific And Industrial Research Analoge von 4-beta-1''-[(2''-(substitutierte-benzoyl)anilin]-podophyllotoxin zur verwendung als antikrebs-agentia 4-beta-1"-∫2"-(substituted benzoyl) anilino∫ podophyllotoxin analogues useful as anticancer agents
US6566393B1 (en) * 2002-06-21 2003-05-20 The University Of North Carolina At Chapel Hill Etoposide analogs and methods of use thereof
EP1603474B1 (en) 2003-02-14 2013-09-11 The Board Of Trustees Of The Leland Stanford Junior University Electrosurgical system with uniformly enhanced electric field and minimal collateral damage
WO2004073375A2 (en) 2003-02-18 2004-09-02 Ranbaxy Laboratories Limited Podophyllotoxin derivatives as antitumor agents

Also Published As

Publication number Publication date
BRPI0509912A (pt) 2007-09-18
TW200604191A (en) 2006-02-01
US7846926B2 (en) 2010-12-07
AU2005233382B2 (en) 2009-07-16
CN1946727A (zh) 2007-04-11
EP1742952B1 (en) 2008-07-30
US9216989B2 (en) 2015-12-22
PL1742952T3 (pl) 2009-01-30
JP4876070B2 (ja) 2012-02-15
MXPA06011886A (es) 2006-12-14
CN1946727B (zh) 2010-08-11
US9403840B2 (en) 2016-08-02
BRPI0509912B1 (pt) 2019-08-27
TWI350288B (en) 2011-10-11
ZA200609055B (en) 2008-06-25
BRPI0509912B8 (pt) 2021-05-25
DK1742952T3 (da) 2008-10-27
RS50628B (sr) 2010-06-30
FR2869035B1 (fr) 2006-07-14
US20110053967A1 (en) 2011-03-03
FR2869035A1 (fr) 2005-10-21
ATE402938T1 (de) 2008-08-15
US20090170843A1 (en) 2009-07-02
PT1742952E (pt) 2008-10-27
CY1108444T1 (el) 2014-04-09
SI1742952T1 (sl) 2008-12-31
HK1095812A1 (en) 2007-05-18
CA2562617A1 (en) 2005-10-27
MY137712A (en) 2009-02-27
CA2562617C (en) 2013-06-11
DE602005008578D1 (de) 2008-09-11
EP1742952A1 (en) 2007-01-17
AR048607A1 (es) 2006-05-10
JP2007532628A (ja) 2007-11-15
US20150368258A1 (en) 2015-12-24
WO2005100363A8 (en) 2006-10-26
AU2005233382C1 (en) 2010-02-04
AU2005233382A1 (en) 2005-10-27
WO2005100363A1 (en) 2005-10-27
ES2311985T3 (es) 2009-02-16

Similar Documents

Publication Publication Date Title
HRP20080542T3 (hr) Acetamidni derivati epipodofilotoksina, postupak njihove priprave i njihova terapijska primjena kaoantikancerogena sredstva
TW200745034A (en) New compounds
UY29312A1 (es) Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones
PE20060285A1 (es) Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp)
TW200612920A (en) Novel imidazolidine derivatives
CO5601030A2 (es) Derivados de quinolinona/benzoxazinona y usos de los mismos
RS50537B (sr) Derivati benzimidazola i njihovo korišćenje kao antagonista receptora a ii
HRP20110498T1 (hr) Azetidini kao inhibitori mek za liječenje proliferativnih bolesti
MY140528A (en) Spiroketal derivatives and their use as therapeutic agents for diabetes
HRP20050390A2 (en) Substituted benzoxazinones and uses thereof
RU2010116253A (ru) Производные n-гидроксилсульфонамида как новые физиологически применимые доноры нитроксила
AR048669A1 (es) Derivados biciclicos de bisamida
BRPI0409938A (pt) derivados de azetidinacarboxamida e seu uso em terapia
TW200606137A (en) Urea derivatives
EP1489077A4 (en) 2- FURANCARA ACID HYDRATES AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
TW200745058A (en) MMP-13 selective inhibitors
EA201171328A1 (ru) Производное замещенного изохинолина
MY160942A (en) Melanin production inhibitor
RS49906B (sr) Benzociklohepteni, postupak za njihovo dobijanje, farmaceutski preparati koji ove sadrže kao i njihova primena za izradu lekova
ECSP077402A (es) Derivados de 2-amido-4-feniltiazol, su preparación y su aplicación en terapéutica
CO5700763A2 (es) Derivados de 1-bencil-5-piperazin-1-il-3,4-dihidro-1h-quinazolin-2-ona y el respexctivo 1h-benzo (1,2,6)tiadiazin-2,2-dioxido y derivados de 1,4-dihidro-benzo (d) (1,3) oxazin-2-ona como moduladores del receptor 5-hidroxitriptamina (5-ht) para el tra
TW200612931A (en) Substituted biphenyl derivatives
ECSP045420A (es) Derivados de benzoxazina como moduladores 5-ht6 y usos de los mismos
CY1111748T1 (el) Παραγωγα 7-αλκυνυλο-1.8-ναφθυριδονων, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη
DK1204662T3 (da) Azaindoler med serotoninreceptoraffinitet